Glenmark Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?
GLENMARK PHARMS has one hundred and ten approved drugs.
There are seven tentative approvals on GLENMARK PHARMS drugs.
Drugs and US Patents for Glenmark Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Pharms | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 209495-002 | May 10, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Glenmark Pharms Ltd | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 077802-003 | Oct 9, 2007 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Glenmark Pharms Ltd | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 203562-002 | Jul 26, 2016 | AB1 | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.